{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:36Z","timestamp":1790610816664,"version":"4.1.0"},"reference-count":114,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Telemedicine and e-Health"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Telemedicine and remote patient monitoring are rapidly growing fields. This scoping review provides an update on remote patient monitoring for neuropsychiatric disorders from recent publications and upcoming clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Publications (PubMed and ICHUSHI; published January 2010 to February 2021) and trials (\n                      <jats:uri xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/ClinicalTrials.gov\">ClinicalTrials.gov<\/jats:uri>\n                      and Japanese registries; active or recruiting by March 2021) that assessed wearable devices for remote management and\/or monitoring of patients with neuropsychiatric disorders were searched. The review focuses on disorders with \u22653 publications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified 44 publications and 51 active or recruiting trials, mostly from 2019 or 2020. Research on digital devices was most common for Parkinson's disease (11 publications and 19 trials), primarily for monitoring motor symptoms and\/or preventing falls. Other disorders (3\u20135 publications each) included epilepsy (electroencephalogram [EEG] and seizure prediction), sleep disorder (sleep outcomes and behavioral therapies), multiple sclerosis (physical activity and symptoms), depression (physical activity, symptoms, and behavioral therapies), and amyotrophic lateral sclerosis (symptoms). Very few studies focused on newly emerging technologies (e.g., in-ear EEG and portable oximeters), and few studies integrated remote symptom monitoring with telemedicine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Currently, development of digital devices for daily symptom monitoring is focused on Parkinson's disease. For the diseases reviewed, studies mostly focused on physical activity rather than psychiatric or nonmotor symptoms. Although the validity and usefulness of many devices are established, models for implementing remote patient monitoring in telehealth settings have not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Verification of the clinical effectiveness of digital devices combined with telemedicine is needed to further advance remote patient care for neuropsychiatric disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/tmj.2021.0489","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T14:43:41Z","timestamp":1643035421000},"page":"1235-1250","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":25,"title":["Remote Patient Monitoring for Neuropsychiatric Disorders: A Scoping Review of Current Trends and Future Perspectives from Recent Publications and Upcoming Clinical Trials"],"prefix":"10.1177","volume":"28","author":[{"given":"Tetsuo","family":"Sakamaki","sequence":"first","affiliation":[{"name":"Medical Informatics and Decision Sciences, Gunma University Graduate School of Medicine, Maebashi, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-1799","authenticated-orcid":false,"given":"Yoshihiko","family":"Furusawa","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Enterprise Digital Lead, Takeda Pharmaceutical Company Limited, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovelle","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2018-0044"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2016.0051"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2020.0339"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2020.0184"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154335"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2018.0101"},{"key":"e_1_3_7_8_2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2017.3826","article-title":"Depression is the leading cause of disability around the world","volume":"317","author":"Friedrich MJ","year":"2017","unstructured":"Friedrich MJ. Depression is the leading cause of disability around the world. JAMA, 2017; 317:1517.","journal-title":"JAMA"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30299-5"},{"key":"e_1_3_7_10_2","volume-title":"Practice Guidelines for the Psychiatric Evaluation of Adults","author":"American Psychiatric Association","year":"2016","unstructured":"American Psychiatric Association. Practice Guidelines for the Psychiatric Evaluation of Adults, 3rd ed. Arlington, VA, 2016."},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-58"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28376"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6624-1"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.8018"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6564"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2009.090604"},{"key":"e_1_3_7_17_2","unstructured":"Tele-epic (Telemedicine for Epilepsy Care) (Tele-epic). ClinicalTrials.gov Identifier: NCT04496310. First posted. 2020. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04496310 (last accessed August11 2021)."},{"key":"e_1_3_7_18_2","unstructured":"An Observational Study to Investigate Utility and Issue of a Platform that Performs the Online Examination with Monitoring Using Digital Devices Online Instruction on the Use of Drugs and Delivering Drugs for Patients with Parkinson's Disease [In Japanese]. JAPIC CTI Identifier: JapicCTI-205296. First posted 2020. Available at https:\/\/rctportal.niph.go.jp\/s\/detail\/jp?trial_id=JapicCTI-205296 (last accessed August11 2021)."},{"key":"e_1_3_7_19_2","unstructured":"Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes\u2014Clinical Trial (MoMoPa-EC). ClinicalTrials.gov Identifier: NCT04176302. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04176302 (last accessed August11 2021)."},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1109\/TNSRE.2017.2690578"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.2196\/19068"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.11.004"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.3791\/59827"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27830"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19235169"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19051129"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19143103"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19235153"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.3390\/s19040948"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/tmj.2015.0026"},{"key":"e_1_3_7_31_2","unstructured":"The Personalized Parkinson Project (PPP). ClinicalTrials.gov Identifier: NCT03364894. First posted. 2017. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03364894 (last accessed August11 2021)."},{"key":"e_1_3_7_32_2","unstructured":"Wearable Assessments in the Clinic and Home in PD (WATCH-PD). ClinicalTrials.gov Identifier: NCT03681015. First posted. 2018. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03681015 (last accessed August11 2021)."},{"key":"e_1_3_7_33_2","unstructured":"Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure (REDWOOD). ClinicalTrials.gov Identifier: NCT03829657. First posted. 2019. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03829657 (last accessed August11 2021)."},{"key":"e_1_3_7_34_2","unstructured":"Improving Walking Ability in Parkinson Disease (PASTA). ClinicalTrials.gov Identifier: NCT03921697. First posted. 2019. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03921697 (last accessed August11 2021)."},{"key":"e_1_3_7_35_2","unstructured":"Digital Wearable Walking Aid for Freezing of Gait in Parkinson's Disease. ClinicalTrials.gov Identifier: NCT03978507. First posted. 2019. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03978507 (last accessed August11 2021)."},{"key":"e_1_3_7_36_2","unstructured":"Sensor-supported Classification of Gait Patterns in Everyday Movement of Patients With Parkinson's Disease (PD-GPC). ClinicalTrials.gov Identifier: NCT04054856. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04054856 (last accessed August11 2021)."},{"key":"e_1_3_7_37_2","unstructured":"Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders. ClinicalTrials.gov Identifier: NCT04231487. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04231487 (last accessed August11 2021)."},{"key":"e_1_3_7_38_2","unstructured":"Gait Characteristics and Cognitive Evolution in Parkinson Disease (GECO-PD). ClinicalTrials.gov Identifier: NCT04297800. First posted. 2020. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04297800 (last accessed August11 2021)."},{"key":"e_1_3_7_39_2","unstructured":"Study Comparing Continuous Subcutaneous Infusion of ABBV-951 with Oral Carbidopa\/Levodopa Tablets for Treatment of Motor Fluctuations in Adult Participants with Advanced Parkinson's Disease. ClinicalTrials.gov Identifier: NCT04380142. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04380142 (last accessed August11 2021)."},{"key":"e_1_3_7_40_2","unstructured":"Usability of a Novel Cueing Device for Patients with Parkinson's Disease (TCP). ClinicalTrials.gov Identifier: NCT04459559. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04459559 (last accessed August11 2021)."},{"key":"e_1_3_7_41_2","unstructured":"Aquaporin-4 Single Nucleotide Polymorphisms in Patients with Idiopathic and Familial Parkinson's Disease. ClinicalTrials.gov Identifier: NCT04553185. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04553185 (last accessed August11 2021)."},{"key":"e_1_3_7_42_2","unstructured":"Novel Paradigms of Deep Brain Stimulation for Movement Disorders. ClinicalTrials.gov Identifier: NCT04563143. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04563143 (last accessed August11 2021)."},{"key":"e_1_3_7_43_2","unstructured":"Therapeutic Swallow Sensor. ClinicalTrials.gov Identifier: NCT04664634. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04664634 (last accessed August11 2021)."},{"key":"e_1_3_7_44_2","unstructured":"Study on Levodopa-Containing Preparation Dose Adjustment of Istradefylline in Parkinson's Disease Patients (intervention study). jRCT Identifier: jRCTs031180248. First posted. 2019. Available at https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=jRCTs031180248 (last accessed August11 2021)."},{"key":"e_1_3_7_45_2","unstructured":"Relationship Between Falls in Parkinson's Disease Patients and Freezing Feet in Clinical and Home Situations. UMIN Identifier: UMIN000041373. First posted. 2020. Available at https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000041373 (last accessed August11 2021)."},{"key":"e_1_3_7_46_2","unstructured":"Non-invasive AI Wearable Device for Supporting Medical care. UMIN Identifier: UMIN000038690. First posted. 2019. Available at https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000044099 (last accessed August11 2021)."},{"key":"e_1_3_7_47_2","unstructured":"An Observational Study for the Application of Wearable Multi-Sensor Technology to Characterize Motor Function of Parkinson's Disease Patients in Japan [In Japanese]. JAPIC CTI Identifier: JapicCTI-194825. First posted 2019. Available at https:\/\/rctportal.niph.go.jp\/s\/detail\/jp?trial_id=JapicCTI-194825 (last accessed August11 2021)."},{"key":"e_1_3_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106507"},{"key":"e_1_3_7_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/03091902.2020.1713238"},{"key":"e_1_3_7_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.106902"},{"key":"e_1_3_7_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.23849"},{"key":"e_1_3_7_52_2","doi-asserted-by":"publisher","DOI":"10.1080\/03091902.2017.1382585"},{"key":"e_1_3_7_53_2","unstructured":"Utilizing Activity Trackers to Promote Physical Activity in People with Epilepsy: Can we Make a Difference? ClinicalTrials.gov Identifier: NCT04357912. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04357912 (last accessed August11 2021)."},{"key":"e_1_3_7_54_2","unstructured":"Subcutaneous EEG: Forecasting of Epileptic Seizures (SUBER). ClinicalTrials.gov Identifier: NCT04061707. First posted 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04061707 (last accessed August11 2021)."},{"key":"e_1_3_7_55_2","unstructured":"Promoting Implementation of Seizure Detection Devices in Epilepsy Care (PROMISE). ClinicalTrials.gov Identifier: NCT03909984. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03909984 (last accessed August11 2021)."},{"key":"e_1_3_7_56_2","unstructured":"Research on Development of Wearable Epilepsy Monitoring Device. UMIN Identifier: UMIN000030494. First posted. 2017. Available at https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_his_list.cgi?recptno=R000034809 (last accessed August11 2021)."},{"key":"e_1_3_7_57_2","unstructured":"Seizure Detection and Warning System for Epilepsy Patients. ClinicalTrials.gov Identifier: NCT01874600. First posted. 2013. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01874600 (last accessed August11 2021)."},{"key":"e_1_3_7_58_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.3356"},{"key":"e_1_3_7_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz146"},{"key":"e_1_3_7_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69935-7"},{"key":"e_1_3_7_61_2","unstructured":"Sleep Health in Preschoolers: A Randomized Controlled Trial (SHIP). ClinicalTrials.gov Identifier: NCT02255721. First posted. 2014. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02255721 (last accessed August11 2021)."},{"key":"e_1_3_7_62_2","unstructured":"Evaluation of Spa Treatment on Insomnia (SOMNOTHERM). ClinicalTrials.gov Identifier: NCT03991247. First posted. 2019. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03991247 (last accessed August11 2021)."},{"key":"e_1_3_7_63_2","unstructured":"The Impact of Insomnia on Pain in HIV (HIPPI). ClinicalTrials.gov Identifier: NCT04298658. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04298658 (last accessed August11 2021)."},{"key":"e_1_3_7_64_2","unstructured":"Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents (Sleepazoid). ClinicalTrials.gov Identifier: NCT04550507. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04550507 (last accessed August11 2021)."},{"key":"e_1_3_7_65_2","unstructured":"Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants. ClinicalTrials.gov Identifier: NCT04445129. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04445129 (last accessed August11 2021)."},{"key":"e_1_3_7_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/abm\/kay018"},{"key":"e_1_3_7_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.10.043"},{"key":"e_1_3_7_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8334-6"},{"key":"e_1_3_7_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0570"},{"key":"e_1_3_7_70_2","unstructured":"Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS-Brain). ClinicalTrials.gov Identifier: NCT04496804. First posted. 2020. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04496804 (last accessed August11 2021)."},{"key":"e_1_3_7_71_2","unstructured":"Development of a Telehealth Obesity Intervention for Patients With MS: Modifying Diet and Exercise in MS (MoDEMS). ClinicalTrials.gov Identifier: NCT04255953. First posted 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04255953 (last accessed August11 2021)."},{"key":"e_1_3_7_72_2","unstructured":"The Impact of Training on Sitting Time and Brain Volumes in Multiple Sclerosis. (EXIMS). ClinicalTrials.gov Identifier: NCT04191772. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04191772 (last accessed August11 2021)."},{"key":"e_1_3_7_73_2","unstructured":"Cognitive Behavioral Therapy Modafinil or Both for Multiple Sclerosis Fatigue (COMBO-MS). ClinicalTrials.gov Identifier: NCT03621761. First posted 2018. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03621761 (last accessed August11 2021)."},{"key":"e_1_3_7_74_2","unstructured":"Dietary Approaches to Treat Multiple Sclerosis-Related Fatigue Study (Waves). ClinicalTrials.gov Identifier: NCT02914964. First posted. 2016. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02914964 (last accessed August11 2021)."},{"key":"e_1_3_7_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12849"},{"key":"e_1_3_7_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.04.099"},{"key":"e_1_3_7_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0000000000001042"},{"key":"e_1_3_7_78_2","unstructured":"Smartwatch-supported Internet-delivered Intervention for Depression. ClinicalTrials.gov Identifier: NCT04568317. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04568317 (last accessed August11 2021)."},{"key":"e_1_3_7_79_2","unstructured":"Internet-Based Behavioral Activation Therapy Via Smartphone for Postnatal Mothers to Reduce Postnatal Depression and Child Abuse: A Randomized Controlled Trial. UMIN Identifier: UMIN000036864. First posted. 2019. Available at https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_his_list.cgi?recptno=R000041986 (last accessed August11 2021)."},{"key":"e_1_3_7_80_2","unstructured":"Preliminary Study on Just-in-Time Intervention Using Wearable Devices Aimed at Improving Sleep\/Waking Rhythm Against Mood Disorder. jRCT Identifier: jRCTs042190044. First posted. 2019. Available at https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCTs042190044 (last accessed August11 2021)."},{"key":"e_1_3_7_81_2","unstructured":"Engaging Self-regulation Targets to Improve Mood and Weight and Understand Mechanism in Depressed and Obese Adults. ClinicalTrials.gov Identifier: NCT03841682. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03841682 (last accessed August11 2021)."},{"key":"e_1_3_7_82_2","unstructured":"Lifestyle Intervention for Young Adults with Serious Mental Illness. ClinicalTrials.gov Identifier: NCT02815813. First posted. 2016. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02815813 (last accessed August11 2021)."},{"key":"e_1_3_7_83_2","unstructured":"Development of Objective Measures for Depression Bipolar Disorder and Dementia by Quantifying Facial Expression Body Movement and Voice Data During Clinical Interview and Daily Activity Utilizing Wearable Device. UMIN Identifier: UMIN000023764. First posted 2016. Available at https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000027146 (last accessed August11 2021)."},{"key":"e_1_3_7_84_2","doi-asserted-by":"publisher","DOI":"10.2196\/13433"},{"key":"e_1_3_7_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2015.06.017"},{"key":"e_1_3_7_86_2","unstructured":"ALS Testing Through Home-based Outcome Measures (ALS AT HOME). ClinicalTrials.gov Identifier: NCT03016897. First posted. 2017. Available at https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03016897 (last accessed August11 2021)."},{"key":"e_1_3_7_87_2","unstructured":"Validation of Tidal\/End-Tidal CO2 in ALS (VOTECO2ALS). ClinicalTrials.gov Identifier: NCT03764384. First posted. 2018. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03764384 (last accessed August11 2021)."},{"key":"e_1_3_7_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61393-3"},{"key":"e_1_3_7_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12733"},{"key":"e_1_3_7_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy158"},{"key":"e_1_3_7_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20213"},{"key":"e_1_3_7_92_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.24"},{"key":"e_1_3_7_93_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000000601"},{"key":"e_1_3_7_94_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.6506"},{"key":"e_1_3_7_95_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.7230"},{"key":"e_1_3_7_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2020.03.017"},{"key":"e_1_3_7_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2019.103464"},{"key":"e_1_3_7_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/da.22640"},{"key":"e_1_3_7_99_2","first-page":"e12111","article-title":"Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19","volume":"12","author":"Geddes MR","year":"2020","unstructured":"Geddes MR, , O'Connell ME, , Fisk JD, et al. Remote cognitive and behavioral assessment: Report of the Alzheimer Society of Canada Task Force on dementia care best practices for COVID-19. Alzheimers Dement (Amst), 2020; 12:e12111.","journal-title":"Alzheimers Dement (Amst)"},{"key":"e_1_3_7_100_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-021-03318-8"},{"key":"e_1_3_7_101_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03121-9"},{"key":"e_1_3_7_102_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2012.00073"},{"key":"e_1_3_7_103_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.741059"},{"key":"e_1_3_7_104_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs136"},{"key":"e_1_3_7_105_2","doi-asserted-by":"publisher","DOI":"10.2196\/12013"},{"key":"e_1_3_7_106_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160348"},{"key":"e_1_3_7_107_2","unstructured":"The Healthy Patterns Sleep Study. ClinicalTrials.gov Identifier: NCT03682185. First posted. 2018. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03682185 (last accessed November11 2021)."},{"key":"e_1_3_7_108_2","unstructured":"Lifestyle Integrated Functional Exercise for People with Dementia: A Home-Based Physical Activity Program (LiFE4D). ClinicalTrials.gov Identifier: NCT03757806. First posted. 2018. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03757806 (last accessed November11 2021)."},{"key":"e_1_3_7_109_2","unstructured":"The Long-Term Impact of a Light Intervention on Sleep and Cognition in Mild Cognitive Impairment. ClinicalTrials.gov Identifier: NCT04073628. First posted. 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04073628 (last accessed November11 2021)."},{"key":"e_1_3_7_110_2","unstructured":"A Dyadic Approach for a Remote Physical Activity Intervention in Adults with AD and Their Caregivers. ClinicalTrials.gov Identifier: NCT04102514. First posted 2019. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04102514 (last accessed November11 2021)."},{"key":"e_1_3_7_111_2","unstructured":"Feasibility of the SmartPrompt for Improving Everyday Function in Dementia (SmartPrompt). ClinicalTrials.gov Identifier: NCT04313582. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04313582 (last accessed November11 2021)."},{"key":"e_1_3_7_112_2","unstructured":"Feasibility of Passive Data Collection in Dementia Subjects with Agitation. ClinicalTrials.gov Identifier: NCT04413851. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04413851 (last accessed November11 2021)."},{"key":"e_1_3_7_113_2","unstructured":"REmote Assessment and Dynamic Response Intervention (READyR). ClinicalTrials.gov Identifier: NCT04542109. First posted. 2020. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04542109 (last accessed November11 2021)."},{"key":"e_1_3_7_114_2","unstructured":"Effect of Exercise for Dementia Including Early Onset Dementia and Mild Cognitive Impairment. UMIN Identifier: UMIN000035097. First posted. 2018. Available at https:\/\/rctportal.niph.go.jp\/s\/detail\/um?trial_id=UMIN000035097 (last accessed November11 2021)."},{"key":"e_1_3_7_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2017.09.028"}],"container-title":["Telemedicine and e-Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/tmj.2021.0489","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/tmj.2021.0489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/tmj.2021.0489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:31:41Z","timestamp":1777588301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/tmj.2021.0489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":114,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1089\/tmj.2021.0489"],"URL":"https:\/\/doi.org\/10.1089\/tmj.2021.0489","relation":{},"ISSN":["1530-5627","1556-3669"],"issn-type":[{"value":"1530-5627","type":"print"},{"value":"1556-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}